Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

Voriconazole (VORI) for the treatment of resistant and rare fungal pathogens.

Publication ,  Conference
Perfect, JR; Lutsar, I; Gonzalez-Ruiz, A
Published in: Clinical Infectious Diseases
July 1, 2000

Duke Scholars

Published In

Clinical Infectious Diseases

ISSN

1058-4838

Publication Date

July 1, 2000

Volume

31

Issue

1

Start / End Page

265 / 265

Publisher

UNIV CHICAGO PRESS

Related Subject Headings

  • Microbiology
  • 11 Medical and Health Sciences
  • 06 Biological Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Perfect, J. R., Lutsar, I., & Gonzalez-Ruiz, A. (2000). Voriconazole (VORI) for the treatment of resistant and rare fungal pathogens. In Clinical Infectious Diseases (Vol. 31, pp. 265–265). UNIV CHICAGO PRESS.
Perfect, J. R., I. Lutsar, and A. Gonzalez-Ruiz. “Voriconazole (VORI) for the treatment of resistant and rare fungal pathogens.” In Clinical Infectious Diseases, 31:265–265. UNIV CHICAGO PRESS, 2000.
Perfect JR, Lutsar I, Gonzalez-Ruiz A. Voriconazole (VORI) for the treatment of resistant and rare fungal pathogens. In: Clinical Infectious Diseases. UNIV CHICAGO PRESS; 2000. p. 265–265.
Perfect, J. R., et al. “Voriconazole (VORI) for the treatment of resistant and rare fungal pathogens.Clinical Infectious Diseases, vol. 31, no. 1, UNIV CHICAGO PRESS, 2000, pp. 265–265.
Perfect JR, Lutsar I, Gonzalez-Ruiz A. Voriconazole (VORI) for the treatment of resistant and rare fungal pathogens. Clinical Infectious Diseases. UNIV CHICAGO PRESS; 2000. p. 265–265.

Published In

Clinical Infectious Diseases

ISSN

1058-4838

Publication Date

July 1, 2000

Volume

31

Issue

1

Start / End Page

265 / 265

Publisher

UNIV CHICAGO PRESS

Related Subject Headings

  • Microbiology
  • 11 Medical and Health Sciences
  • 06 Biological Sciences